Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
InVivo Therapeutics Holdings Corporation | NVIV | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.3207 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
21/3/2024 | 13:23 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
14/2/2024 | 13:53 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 19:09 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
07/2/2024 | 13:12 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
07/2/2024 | 12:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
06/2/2024 | 11:08 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
06/2/2024 | 07:00 | EDGAR2 | Form 8-K - Current report |
01/2/2024 | 07:00 | EDGAR2 | Form 8-K - Current report |
05/12/2023 | 07:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
01/12/2023 | 15:30 | EDGAR2 | Form 8-K - Current report |
30/11/2023 | 09:31 | EDGAR2 | Form 8-K - Current report |
08/11/2023 | 15:31 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
01/9/2023 | 15:30 | EDGAR2 | Form 8-K - Current report |
09/8/2023 | 15:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |